NEW

Siemens Healthineers to Acquire Varian

Siemens Healthineers AG and Varian Medical Systems Inc. have entered into an agreement, pursuant to which Siemens Healthineers shall acquire all shares of Varian for $177.50 per share in cash. This corresponds to a purchase price of approximately $16.4 billion....

MTMI Partners with Nautilus Medical Technologies

The Medical Technology Management Institute (MTMI), a division of The College of Health Care Professions, has announced a partnership with Nautilus Medical Technologies, developer of a cloud-based imaging sharing platform used by over a thousand health care providers...

Gillette Children’s Specialty Healthcare is the first U.S. hospital to image patients with EOSedge

EOS imaging, a provider of 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning, has announced the first exams performed with EOSedge in the United States, at Gillette Children's Specialty Healthcare’s main campus...

Webinar on FDA’s Regulation of Face Masks and Surgical Masks during the COVID-19 Pandemic

On Tuesday, August 4, 12:00 p.m.-1:00 p.m. ET, the U.S. Food and Drug Administration (FDA) will host a webinar on the FDA’s regulation of face masks and surgical masks during the COVID-19 pandemic. This webinar will expand the scope of the respirator webinar series to...

KA Imaging Launching Portable Dual-Energy X-ray Detector

For the first time, practitioners will be able to leverage dual-energy X-ray technology in a portable system. Canadian manufacturer KA Imaging is getting ready to launch Reveal, the world’s first dual-energy X-ray detector that can be taken to the bedside.

“Due to infectious nature of COVID-19, bringing patients into a fixed radiology room can sometimes be risky,” explains Amol Karnick, president and CEO of KA Imaging. “Current dual-energy systems are all fixed and Reveal overcomes the limitation of a fixed room by providing a world first portable dual energy solution. Reveal provides radiologists with an unobstructed view of the lungs by removing the bones in an X-ray image.”

The FDA 510(k) pending detector works with a single exposure. Unlike fixed dual energy solutions, Reveal’s technology enables bone and soft tissue differentiation with no motion artifact.

“Our patented technology also allows lateral and oblique dual energy views for the first time,” explains Dr. Karim S. Karim, CTO at KA Imaging.

Whereas fixed dual-energy systems can cost as high as half a million dollars, KA Imaging’s Reveal is highly affordable at less than quarter of this price.

“If a hospital requires dual energy X-ray for COVID-19, you can simply replace any older CR plate or digital fixed or portable detector with Reveal,” says Amol.

The company is planning clinical trials globally to demonstrate the efficacy of Reveal in triaging COVID-19 and other imaging tasks in the emergency room and intensive care units. One of them is expected to begin in Toronto by August.

“The world needs affordable and effective portable bedside diagnostics now, and Reveal is a solution that can provide tremendous value for clinicians, hospitals and government,” emphasizes Karim.

Reveal is also being tested on patients with lung cancer. Grand River Hospital (Kitchener, Ontario, Canada) was the first to test the technology. More than 20 patients have been imaged with Reveal, with promising initial results.

Radiologists globally can learn more about Reveal at the European Congress of Radiology (ECR) from July 15-19. Due to the pandemic, the conference will be held online. KA Imaging is part of the virtual exhibition.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *